» »
Transparency
Disclaimer by PETSIAVAS SA pursuant to the provisions of Article 66, para. 7a of Law 4316/2014, the EFPIA Disclosure Code, Opinion 5/2016 and Opinion 2/2017 by the Hellenic Data Protection Authority
This page discloses, by name, the transfer of values granted by PETSIAVAS SA to Healthcare Organisations (HCO) from 01/01/2016.
We reserve the right to keep updated disclosures pending the final instructions by Management’s stakeholders.
n any event, this disclosure aims at enhancing transparency between pharmaceutical companies and healthcare professionals (HCPs) and healthcare organisations (HCOs) and in defending the patients’ right of knowing the relationship between pharmaceutical companies and the scientific society.